Free Trial

First Trust Nasdaq Pharmaceuticals ETF Rating

First Trust Nasdaq Pharmaceuticals ETF logo
$27.38 +0.25 (+0.92%)
(As of 11/20/2024 ET)

First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

FTXH Aggregate Rating

Moderate Buy
2.60

Holdings in FTXH have an aggregate rating of Moderate Buy based on 727 analyst ratings issued in the past year covering 50 companies (99.8% of the portfolio).

FTXH Aggregate Price Target

$27.38
High Prediction$27.38
Average Prediction$27.38
Low Prediction$27.38

Holdings in FTXH have an aggregate price target of $27.38 and a range of $27.38 to $27.38 covering 50 companies (99.8% of the portfolio).

FTXH Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
Moderate Buy
30 Moderate Buy rating(s)
Hold
8 Hold rating(s)
Reduce
1 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 50 FTXH Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
8.92%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$58.00
+0.2%
4.7781 of 5 stars
2.20$54.07 -6.8%20Analyst Revision
7.32%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$153.54
+0.3%
4.9639 of 5 stars
2.53$175.94 14.6%15Positive News
6.72%
Pfizer Inc. stock logo
PFE
Pfizer
$24.86
-0.3%
5 of 5 stars
2.50$32.92 32.4%16Analyst Downgrade
Analyst Revision
6.64%
AbbVie Inc. stock logo
ABBV
AbbVie
$167.45
-0.2%
4.9624 of 5 stars
2.90$203.37 21.5%21Analyst Forecast
Positive News
6.39%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$97.50
+0.1%
4.9964 of 5 stars
2.68$130.86 34.2%19Dividend Increase
Positive News
4.39%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$88.27
-0.4%
4.549 of 5 stars
2.65$94.45 7.0%26Analyst Upgrade
Positive News
4.22%
Viatris Inc. stock logo
VTRS
Viatris
$13.13
1.3514 of 5 stars
2.00$13.33 1.5%3
4.17%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$120.34
+1.7%
4.8258 of 5 stars
2.46$123.00 2.2%13
3.77%
Zoetis Inc. stock logo
ZTS
Zoetis
$175.67
+0.1%
4.8598 of 5 stars
3.10$221.44 26.1%10Positive News
3.74%
United Therapeutics Co. stock logo
UTHR
United Therapeutics
$364.33
+1.0%
4.5219 of 5 stars
2.73$370.86 1.8%15Analyst Revision
Positive News
3.37%
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
$121.40
+1.8%
4.9183 of 5 stars
2.80$175.33 44.4%15Analyst Forecast
3.27%
Amgen Inc. stock logo
AMGN
Amgen
$285.11
-1.0%
4.9084 of 5 stars
2.46$333.57 17.0%26Ex-Dividend
Short Interest ↓
3.02%
Biogen Inc. stock logo
BIIB
Biogen
$154.88
-0.4%
4.8649 of 5 stars
2.54$257.20 66.1%28Analyst Downgrade
2.97%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$755.20
+0.2%
4.9913 of 5 stars
2.81$1,007.94 33.5%21Analyst Revision
2.52%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$743.35
-0.2%
4.7877 of 5 stars
2.78$1,099.55 47.9%23
2.48%
Organon & Co. stock logo
OGN
Organon & Co.
$14.78
+0.3%
4.7298 of 5 stars
2.50$21.33 44.3%4
2.43%
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$187.90
+1.0%
4.8024 of 5 stars
1.93$214.38 14.1%15Analyst Downgrade
1.81%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$13.44
+1.0%
4.1237 of 5 stars
2.43$17.14 27.6%7
1.71%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$326.09
+3.5%
4.7711 of 5 stars
2.45$380.00 16.5%11
1.37%
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$122.60
-0.6%
4.9503 of 5 stars
2.83$163.91 33.7%24Positive News
1.14%
Exelixis, Inc. stock logo
EXEL
Exelixis
$34.72
+0.2%
4.7763 of 5 stars
2.65$31.44 -9.4%20Insider Trade
1.07%
Alkermes plc stock logo
ALKS
Alkermes
$28.01
+0.4%
4.7847 of 5 stars
2.58$35.42 26.4%12Positive News
1.00%
Perrigo Company plc stock logo
PRGO
Perrigo
$27.15
-0.3%
4.9798 of 5 stars
2.75$37.00 36.3%4Positive News
0.99%
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
$82.67
+0.3%
3.6888 of 5 stars
2.67$83.67 1.2%3
0.97%
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$45.69
-0.2%
4.9812 of 5 stars
2.60$61.11 33.8%10Analyst Forecast
0.81%
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
$55.00
-1.9%
4.6673 of 5 stars
3.00$65.25 18.6%5
0.72%
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
$40.65
+5.2%
3.0296 of 5 stars
3.14$53.57 31.8%7Analyst Forecast
Analyst Revision
News Coverage
0.70%
Arcellx, Inc. stock logo
ACLX
Arcellx
$87.22
-0.4%
2.9324 of 5 stars
3.07$103.08 18.2%14Short Interest ↓
0.69%
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$31.83
+2.2%
4.2178 of 5 stars
2.83$37.67 18.3%6Positive News
0.64%
Incyte Co. stock logo
INCY
Incyte
$71.05
+0.7%
3.912 of 5 stars
2.38$77.16 8.6%21Analyst Forecast
0.61%
ADMA Biologics, Inc. stock logo
ADMA
ADMA Biologics
$21.45
+0.4%
3.3177 of 5 stars
3.25$21.25 -0.9%4
0.61%
Intra-Cellular Therapies, Inc. stock logo
ITCI
Intra-Cellular Therapies
$85.96
+0.4%
4.4721 of 5 stars
2.85$97.23 13.1%13Positive News
0.60%
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$247.58
-0.5%
4.3981 of 5 stars
2.71$298.09 20.4%24Analyst Forecast
0.56%
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$15.76
-2.8%
3.9104 of 5 stars
2.65$25.56 62.2%17Insider Trade
Analyst Revision
0.56%
Vericel Co. stock logo
VCEL
Vericel
$57.26
+2.6%
1.0997 of 5 stars
3.00$58.14 1.5%7Analyst Forecast
0.52%
Twist Bioscience Co. stock logo
TWST
Twist Bioscience
$40.69
-1.0%
4.1398 of 5 stars
2.67$51.78 27.2%9Analyst Forecast
Analyst Revision
News Coverage
0.52%
Amneal Pharmaceuticals, Inc. stock logo
AMRX
Amneal Pharmaceuticals
$8.38
-0.4%
3.211 of 5 stars
2.80$10.00 19.3%5Insider Trade
0.51%
Blueprint Medicines Co. stock logo
BPMC
Blueprint Medicines
$94.81
+0.2%
2.713 of 5 stars
2.71$122.11 28.8%21Analyst Forecast
Analyst Revision
0.51%
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$43.06
-1.4%
2.4064 of 5 stars
3.00$63.22 46.8%9Insider Trade
Analyst Revision
0.51%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$445.25
-1.3%
4.0527 of 5 stars
2.53$499.12 12.1%30Analyst Downgrade
News Coverage
Positive News
0.50%
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$11.62
+1.1%
3.2845 of 5 stars
2.88$17.93 54.3%8
0.49%
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$177.89
-0.1%
4.7558 of 5 stars
3.00$202.29 13.7%8Positive News
0.48%
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
$43.83
-0.5%
1.4071 of 5 stars
2.81$52.13 18.9%16Analyst Forecast
0.47%
Insmed Incorporated stock logo
INSM
Insmed
$71.86
-1.1%
4.0562 of 5 stars
3.00$83.07 15.6%16
0.44%
Exact Sciences Co. stock logo
EXAS
Exact Sciences
$52.29
-0.8%
4.8868 of 5 stars
2.95$74.47 42.4%19Positive News
0.42%
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
$62.56
+1.0%
4.9885 of 5 stars
2.74$94.20 50.6%23Analyst Revision
0.42%
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$109.71
-1.0%
4.914 of 5 stars
3.00$181.33 65.3%22Analyst Downgrade
Gap Up
0.42%
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
$50.76
-1.5%
4.7696 of 5 stars
3.09$109.80 116.3%11Analyst Forecast
Gap Up
0.39%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$35.40
+4.9%
4.2328 of 5 stars
2.68$60.65 71.3%19
0.29%
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
$15.30
+2.0%
4.2579 of 5 stars
2.42$27.36 78.8%12Analyst Forecast

This page (NASDAQ:FTXH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners